Professor Geert Leroux-Roels, Centre for Vaccinology, Ghent University and Hospital, Belgium and colleagues report on an “antigen sparing adjuvant strategy”, which, by combining the vaccine with an oil-in-water emulsion “adjuvant”, allows the body to produce up to six times as many bird influenza virus neutralising antibodies as it would with an non-adjuvanted vaccine with the same dose.
The bird flu strain H5N1 is widely regarded as the probable cause of the next global influenza pandemic. This virus contains a H5 haemagglutinin antigen subtype, which generally produces a poor immunogenic response in humans and to which most of the world population is immunologically naïve. As a result, the one-dose schedule routinely used for seasonal “regular” influenza vaccines is unlikely to be sufficient to give immunity. The authors say: “Clearly, new formulations that require less antigen per dose are needed. The use of adjuvant to improve immunogenicity is a crucial antigen-sparing strategy.”
The researchers did a study of eight groups of 50 volunteers aged 18-60 years, and studied four antigen doses (3.8µg, 7.5µg, 15µg, 30µg haemagglutinin) given with or without the oil-water adjuvant. Blood samples were then collected to analyse the immune response, and the results showed that the adjuvanted formulations were significantly more immunogenic than the non-adjuvanted formulations at all doses. All eight vaccine formulations had good safety profiles, although the adjuvanted vaccines produced more injection-site symptoms and general symptoms (most of which were mild to moderate and transient) than the non-adjuvanted vaccines.
The authors say that the ability of the 3.8µg dose of the adjuvanted vaccine to induce cross-immunity against the clade two* H5N1 Indonesia strain in more than the three-quarters of individuals with neutralising titres which are six times higher than the non-adjuvanted formulation “represents significant antigen sparing that could increase the number of recipients of the pandemic influenza vaccine.”
They conclude: “The cross-clade neutralising antibody responses recorded imply that such a vaccine could be deployed before pandemic outbreak, which is an important mitigation strategy proposed for pandemic influenza.”
In an accompanying Comment, Dr Suryaprakash Sambhara, Centers for Disease Control and Prevention, Atlanta, Georgia, USA and Dr Gregory Poland, Mayo Clinic and Foundation, Minnesota, USA, say: “Leroux-Roels and colleagues’ study is the first to show significant antigen dose-sparing, high levels of immunogenicity in association with a novel adjuvant, and the induction of cross-clade immunity against A/H5N1 viruses. Their study lends support for considering a strategy of immunising some groups with prepandemic vaccines for preparedness in the event of a pandemic from an H5N1 virus. This vaccine appears to be an important step forward in our ability to protect against the pandemic threat posed by highly pathogenic influenza A/H5N1 viruses.”
Tony Kirby | alfa
Second cause of hidden hearing loss identified
20.02.2017 | Michigan Medicine - University of Michigan
Prospect for more effective treatment of nerve pain
20.02.2017 | Universität Zürich
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
20.02.2017 | Materials Sciences
20.02.2017 | Health and Medicine
20.02.2017 | Health and Medicine